NCT00040066

Brief Summary

The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started May 2002

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2002

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2002

Completed
Same day until next milestone

First Posted

Study publicly available on registry

June 18, 2002

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2003

Completed
Last Updated

January 11, 2017

Status Verified

September 1, 2004

First QC Date

June 18, 2002

Last Update Submit

January 10, 2017

Conditions

Cocaine-Related Disorders

Outcome Measures

Primary Outcomes (2)

  • Cocaine craving

  • Cocaine related high

Interventions

Cocaine (IV)PROCEDURE

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Cocaine dependent, non treatment seeking individuals

You may not qualify if:

  • Please contact site directly for details.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UCLA Integrated Substance Abuse Program

Los Angeles, California, 90024, United States

Location

University of Texas Health Science Center

San Antonio, Texas, 78284, United States

Location

MeSH Terms

Conditions

Cocaine-Related Disorders

Interventions

Cocaine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TropanesAzabicyclo CompoundsAza CompoundsOrganic ChemicalsAlkaloidsHeterocyclic CompoundsBridged Bicyclo Compounds, HeterocyclicHeterocyclic Compounds, Bridged-Ring

Study Officials

  • John Roache, Ph.D.

    National Institute on Drug Abuse (NIDA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

June 18, 2002

First Posted

June 18, 2002

Study Start

May 1, 2002

Study Completion

August 1, 2003

Last Updated

January 11, 2017

Record last verified: 2004-09

Locations

US(2)